229 related articles for article (PubMed ID: 29425201)
21. Treatment Success in Trypanosoma cruzi Infection Is Predicted by Early Changes in Serially Monitored Parasite-Specific T and B Cell Responses.
Alvarez MG; Bertocchi GL; Cooley G; Albareda MC; Viotti R; Perez-Mazliah DE; Lococo B; Castro Eiro M; Laucella SA; Tarleton RL
PLoS Negl Trop Dis; 2016 Apr; 10(4):e0004657. PubMed ID: 27128444
[TBL] [Abstract][Full Text] [Related]
22. Assessment of Liaison XL Murex Chagas diagnostic performance in blood screening for Chagas disease using a reference array of chimeric antigens.
Santos EF; Leony LM; Silva ÂAO; Daltro RT; Freitas NEM; Vasconcelos LCM; de Araújo FLV; Celedon PAF; Krieger MA; Zanchin NIT; Santos FLN
Transfusion; 2021 Sep; 61(9):2701-2709. PubMed ID: 34240750
[TBL] [Abstract][Full Text] [Related]
23. Lack of evidence of seronegative infection in an endemic area of Chagas disease.
Oliveira LC; Lee TH; Ferreira AM; Bierrenbach AL; Souza-Basqueira M; Oliveira CDL; Cardoso CS; Moreira CHV; Oikawa MK; Ribeiro ALP; Busch MP; Sabino EC
Rev Inst Med Trop Sao Paulo; 2019 Feb; 61():e11. PubMed ID: 30785565
[TBL] [Abstract][Full Text] [Related]
24. Parasitaemia and parasitic load are limited targets of the aetiological treatment to control the progression of cardiac fibrosis and chronic cardiomyopathy in Trypanosoma cruzi-infected dogs.
Caldas IS; Menezes APJ; Diniz LF; Nascimento ÁFDSD; Novaes RD; Caldas S; Bahia MT
Acta Trop; 2019 Jan; 189():30-38. PubMed ID: 30290285
[TBL] [Abstract][Full Text] [Related]
25. Genome-wide screening and identification of new Trypanosoma cruzi antigens with potential application for chronic Chagas disease diagnosis.
Reis-Cunha JL; Mendes TA; de Almeida Lourdes R; Ribeiro DR; Machado-de-Avila RA; de Oliveira Tavares M; Lemos DS; Câmara AC; Olórtegui CC; de Lana M; da Cunha Galvão LM; Fujiwara RT; Bartholomeu DC
PLoS One; 2014; 9(9):e106304. PubMed ID: 25225853
[TBL] [Abstract][Full Text] [Related]
26. Relationship between long-term resistance to Trypanosoma cruzi and latent infection, examined by antibody production and polymerase chain reaction in mice.
Basombrío MA; Segura MA; Nasser JR
J Parasitol; 2002 Dec; 88(6):1107-12. PubMed ID: 12537102
[TBL] [Abstract][Full Text] [Related]
27. Human infectiousness and parasite load in chronic patients seropositive for Trypanosoma cruzi in a rural area of the Argentine Chaco.
Macchiaverna NP; Enriquez GF; Bua J; Fernández MP; Sartor PA; Gürtler RE; Cardinal MV
Infect Genet Evol; 2020 Mar; 78():104062. PubMed ID: 31683004
[TBL] [Abstract][Full Text] [Related]
28. How to improve the early diagnosis of Trypanosoma cruzi infection: relationship between validated conventional diagnosis and quantitative DNA amplification in congenitally infected children.
Bua J; Volta BJ; Perrone AE; Scollo K; Velázquez EB; Ruiz AM; De Rissio AM; Cardoni RL
PLoS Negl Trop Dis; 2013; 7(10):e2476. PubMed ID: 24147166
[TBL] [Abstract][Full Text] [Related]
29. Aptamer based, non-PCR, non-serological detection of Chagas disease biomarkers in Trypanosoma cruzi infected mice.
Nagarkatti R; de Araujo FF; Gupta C; Debrabant A
PLoS Negl Trop Dis; 2014; 8(1):e2650. PubMed ID: 24454974
[TBL] [Abstract][Full Text] [Related]
30. Comparing in vivo bioluminescence imaging and the Multi-Cruzi immunoassay platform to develop improved Chagas disease diagnostic procedures and biomarkers for monitoring parasitological cure.
Francisco AF; Saade U; Jayawardhana S; Pottel H; Scandale I; Chatelain E; Liehl P; Kelly JM; Zrein M
PLoS Negl Trop Dis; 2022 Oct; 16(10):e0010827. PubMed ID: 36190992
[TBL] [Abstract][Full Text] [Related]
31. Accuracy of chimeric proteins in the serological diagnosis of chronic chagas disease - a Phase II study.
Santos FL; Celedon PA; Zanchin NI; de Souza WV; da Silva ED; Foti L; Krieger MA; Gomes YM
PLoS Negl Trop Dis; 2017 Mar; 11(3):e0005433. PubMed ID: 28273127
[TBL] [Abstract][Full Text] [Related]
32. Benznidazole treatment in chronic children infected with Trypanosoma cruzi: serological and molecular follow-up of patients and identification of Discrete Typing Units.
Rumi MM; Pérez Brandán C; Gil JF; D'Amato AM; Ragone PG; Lauthier JJ; Tomasini N; Cimino RO; Orellana V; Lacunza CD; Nasser JR; Basombrío MA; Diosque P
Acta Trop; 2013 Oct; 128(1):130-6. PubMed ID: 23880286
[TBL] [Abstract][Full Text] [Related]
33. Sustained Domestic Vector Exposure Is Associated With Increased Chagas Cardiomyopathy Risk but Decreased Parasitemia and Congenital Transmission Risk Among Young Women in Bolivia.
Kaplinski M; Jois M; Galdos-Cardenas G; Rendell VR; Shah V; Do RQ; Marcus R; Pena MS; Abastoflor Mdel C; LaFuente C; Bozo R; Valencia E; Verastegui M; Colanzi R; Gilman RH; Bern C;
Clin Infect Dis; 2015 Sep; 61(6):918-26. PubMed ID: 26063720
[TBL] [Abstract][Full Text] [Related]
34. Flow cytometry, a new approach to detect anti-live trypomastigote antibodies and monitor the efficacy of specific treatment in human Chagas' disease.
Martins-Filho OA; Pereira ME; Carvalho JF; Cançado JR; Brener Z
Clin Diagn Lab Immunol; 1995 Sep; 2(5):569-73. PubMed ID: 8548536
[TBL] [Abstract][Full Text] [Related]
35. Usefulness of the polymerase chain reaction for monitoring cure of mice infected with different Trypanosoma cruzi clonal genotypes following treatment with benznidazole.
Miyamoto CT; Gomes ML; Marangon AV; de Araújo SM; Bahia MT; Martins-Filho OA; de Lana M; de Ornelas Toledo MJ
Exp Parasitol; 2008 Sep; 120(1):45-9. PubMed ID: 18533149
[TBL] [Abstract][Full Text] [Related]
36. International study to evaluate PCR methods for detection of Trypanosoma cruzi DNA in blood samples from Chagas disease patients.
Schijman AG; Bisio M; Orellana L; Sued M; Duffy T; Mejia Jaramillo AM; Cura C; Auter F; Veron V; Qvarnstrom Y; Deborggraeve S; Hijar G; Zulantay I; Lucero RH; Velazquez E; Tellez T; Sanchez Leon Z; Galvão L; Nolder D; Monje Rumi M; Levi JE; Ramirez JD; Zorrilla P; Flores M; Jercic MI; Crisante G; Añez N; De Castro AM; Gonzalez CI; Acosta Viana K; Yachelini P; Torrico F; Robello C; Diosque P; Triana Chavez O; Aznar C; Russomando G; Büscher P; Assal A; Guhl F; Sosa Estani S; DaSilva A; Britto C; Luquetti A; Ladzins J
PLoS Negl Trop Dis; 2011 Jan; 5(1):e931. PubMed ID: 21264349
[TBL] [Abstract][Full Text] [Related]
37. Trypanosoma cruzi infection associated with atypical clinical manifestation during the acute phase of the Chagas disease.
Rangel-Gamboa L; López-García L; Moreno-Sánchez F; Hoyo-Ulloa I; Vega-Mémije ME; Mendoza-Bazán N; Romero-Valdovinos M; Olivo-Díaz A; Villalobos G; Martínez-Hernández F
Parasit Vectors; 2019 Oct; 12(1):506. PubMed ID: 31666114
[TBL] [Abstract][Full Text] [Related]
38. Comparison of conventional serology and PCR methods for the routine diagnosis of Trypanosoma cruzi infection.
Gilber SR; Alban SM; Gobor L; Bescrovaine Jde O; Myiazaki MI; Thomaz-Soccol V
Rev Soc Bras Med Trop; 2013; 46(3):310-5. PubMed ID: 23856879
[TBL] [Abstract][Full Text] [Related]
39. Differential parasitological, molecular, and serological detection of Trypanosoma cruzi I, II, and IV in blood of experimentally infected mice.
Margioto Teston AP; Paula de Abreu A; Gruendling AP; Bahia MT; Gomes ML; Marques de Araújo S; Jean de Ornelas Toledo M
Exp Parasitol; 2016 Jul; 166():44-50. PubMed ID: 26995535
[TBL] [Abstract][Full Text] [Related]
40. Early diagnosis of congenital Trypanosoma cruzi infection using PCR, hemoculture, and capillary concentration, as compared with delayed serology.
Mora MC; Sanchez Negrette O; Marco D; Barrio A; Ciaccio M; Segura MA; Basombrío MA
J Parasitol; 2005 Dec; 91(6):1468-73. PubMed ID: 16539033
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
